FindMyRecallSubscribe
Class II: temporary or reversible health riskCompleted

Sun Pharmaceutical Industries Febuxostat Tablets 40mg Recall

Febuxostat Tablets 40mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceut…

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class II
Reported by FDA
Jan 31, 2024
Recall ID
D-0264-2024
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Febuxostat Tablets 40mg starting Jan 18, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0264-2024 on Jan 31, 2024. Reason: CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment. Status: Completed.

Why it was recalled

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Product description

Febuxostat Tablets 40mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191 (U.T. of D & NH), INDIA, NDC 47335-721-83.

Lot numbers, UPCs & expiration codes

Lot #s: DNE0866B Exp. 06/30/2025, DNE1045A, DNE1046B Exp. 08/31/2025

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0264-2024
Classification
Class II
Status
Completed
Recall initiated
Jan 18, 2024
FDA report date
Jan 31, 2024
Quantity
55,272 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-0264-2024, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Completed
Country
United States
Event ID
93820
Address
2 Independence Way
Code information
Lot #s: DNE0866B Exp. 06/30/2025, DNE1045A, DNE1046B Exp. 08/31/2025
Postal code
08540-6620
Report date
Jan 31, 2024
Product type
Drugs
Recall number
D-0264-2024
Classification
Class II
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Product quantity
55,272 bottles
Reason for recall
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Febuxostat Tablets 40mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191 (U.T. of D & NH), INDIA, NDC 47335-721-83.
Distribution pattern
Nationwide in the USA
Recall initiation date
Jan 18, 2024
Initial firm notification
Letter
Center classification date
Jan 25, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0264-2024, published Jan 31, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls